95 related articles for article (PubMed ID: 21467188)
1. Multiple sclerosis in Hispanics: a study of clinical disease expression.
Amezcua L; Lund BT; Weiner LP; Islam T
Mult Scler; 2011 Aug; 17(8):1010-6. PubMed ID: 21467188
[TBL] [Abstract][Full Text] [Related]
2. Is late-onset multiple sclerosis associated with a worse outcome?
Tremlett H; Devonshire V
Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
[TBL] [Abstract][Full Text] [Related]
3. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
[TBL] [Abstract][Full Text] [Related]
4. Natural history of multiple sclerosis: a unifying concept.
Confavreux C; Vukusic S
Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
[TBL] [Abstract][Full Text] [Related]
5. Sibling disability risk at onset and during disease progression in familial multiple sclerosis.
Wellek A; Korsukewitz C; Bach JP; Schock S; Eienbröker C; Seitz F; Spengler A; Hemmer B; Schlegel K; Oertel WH; Sommer N; Tackenberg B
Mult Scler; 2011 Sep; 17(9):1060-6. PubMed ID: 21561958
[TBL] [Abstract][Full Text] [Related]
6. Benign multiple sclerosis in Crete.
Mastorodemos V; Nikolakaki H; Tzagournissakis M; Kotzamani D; Panou T; Spanaki C; Klados G; Maris T; Kontolaimaki E; Psaroudaki K; Chlouverakis G; Georgakakis G; Plaitakis A
Mult Scler; 2010 Jun; 16(6):701-6. PubMed ID: 20237192
[TBL] [Abstract][Full Text] [Related]
7. Clinical Expression of Multiple Sclerosis in Hispanic Whites of Primarily Caribbean Ancestry.
Hadjixenofontos A; Beecham AH; Manrique CP; Pericak-Vance MA; Tornes L; Ortega M; Rammohan KW; McCauley JL; Delgado SR
Neuroepidemiology; 2015; 44(4):262-8. PubMed ID: 26184860
[TBL] [Abstract][Full Text] [Related]
8. Natural history of secondary-progressive multiple sclerosis.
Tremlett H; Yinshan Zhao ; Devonshire V
Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
[TBL] [Abstract][Full Text] [Related]
9. The natural history of primary progressive multiple sclerosis.
Koch M; Kingwell E; Rieckmann P; Tremlett H
Neurology; 2009 Dec; 73(23):1996-2002. PubMed ID: 19996074
[TBL] [Abstract][Full Text] [Related]
10. The clinical course of multiple sclerosis patients in Hong Kong.
Lau KK; Wong WW; Sheng B; Yu IT; Fung BH; Li HL; Ma KF; Wong LK; Li PC
J Neurol Sci; 2008 May; 268(1-2):78-82. PubMed ID: 18068191
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features of familial multiple sclerosis in Spain].
Fernández-Pérez MJ; Barakat O; García-Moreno JM; Lucas M; Navarro G; Gata JM; Gamero MA; Duque P; Izquierdo G
Rev Neurol; 1999 Oct 16-31; 29(8):693-6. PubMed ID: 10560101
[TBL] [Abstract][Full Text] [Related]
12. Natural history of multiple sclerosis with childhood onset.
Renoux C; Vukusic S; Mikaeloff Y; Edan G; Clanet M; Dubois B; Debouverie M; Brochet B; Lebrun-Frenay C; Pelletier J; Moreau T; Lubetzki C; Vermersch P; Roullet E; Magy L; Tardieu M; Suissa S; Confavreux C;
N Engl J Med; 2007 Jun; 356(25):2603-13. PubMed ID: 17582070
[TBL] [Abstract][Full Text] [Related]
13. Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients.
Debouverie M; Laforest L; Van Ganse E; Guillemin F;
Mult Scler; 2009 Feb; 15(2):251-7. PubMed ID: 19181774
[TBL] [Abstract][Full Text] [Related]
14. Management of worsening multiple sclerosis with mitoxantrone: a review.
Fox EJ
Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
[TBL] [Abstract][Full Text] [Related]
15. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
Ozakbas S; Ormeci B; Idiman E
J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
[TBL] [Abstract][Full Text] [Related]
16. [Optic neuritis as the initial manifestation of multiple sclerosis].
Potemkowski A
Klin Oczna; 2000; 102(2):95-8. PubMed ID: 10932888
[TBL] [Abstract][Full Text] [Related]
17. Are initial demyelinating event recovery and time to second event under differential control?
West T; Wyatt M; High A; Bostrom A; Waubant E
Neurology; 2006 Sep; 67(5):809-13. PubMed ID: 16966542
[TBL] [Abstract][Full Text] [Related]
18. Arylsulfatase a gene polymorphisms in relapsing remitting multiple sclerosis: genotype-phenotype correlation and estimation of disease progression.
Baronica KB; Mlinac K; Ozretić D; Vladić A; Bognar SK
Coll Antropol; 2011 Jan; 35 Suppl 1():11-6. PubMed ID: 21648305
[TBL] [Abstract][Full Text] [Related]
19. Disability progression in multiple sclerosis is slower than previously reported.
Tremlett H; Paty D; Devonshire V
Neurology; 2006 Jan; 66(2):172-7. PubMed ID: 16434648
[TBL] [Abstract][Full Text] [Related]
20. Relapses and progression of disability in multiple sclerosis.
Confavreux C; Vukusic S; Moreau T; Adeleine P
N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
